EcoR1 Capital
North America, California, United States, San Francisco
Description
EcoR1 Capital is a biotech-focused investment advisory firm.
Investor Profile
EcoR1 Capital has made 124 investments, with 11 in the past 12 months and 15% as lead.
Stage Focus
- Post Ipo Equity (36%)
- Series B (22%)
- Series C (16%)
- Series A (15%)
- Private Equity (3%)
- Series Unknown (3%)
- Series D (2%)
- Series E (2%)
- Post Ipo Debt (1%)
Country Focus
- United States (94%)
- Canada (3%)
- Germany (1%)
- The Netherlands (1%)
- United Kingdom (1%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Austria (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Life Science
- Biopharma
- Genetics
- Oncology
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
